+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

From
From
Nasopharyngeal Cancer Market Report and Forecast 2024-2032 - Product Thumbnail Image

Nasopharyngeal Cancer Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Synovial Sarcoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Synovial Sarcoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Allogeneic T Cell Therapies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Allogeneic T Cell Therapies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Immunotherapy Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Immunotherapy Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
T-Cell Malignancies - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Malignancies - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 280 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
Peanut Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
From
Birch Pollen Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HER2-positive Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2-positive Gastric Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
LAG-3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025 - Product Thumbnail Image

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myc Proto Oncogene Protein - Pipeline Insight, 2025 - Product Thumbnail Image

Myc Proto Oncogene Protein - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 96 Pages
  • Global
From
TIGIT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

TIGIT Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CD47 Antigen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

CD47 Antigen Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more